SCHEMBL6689045

SCHEMBL6689045

O=C(O)CC(c1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
HSD17B10 Q99714 2/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
TNF P01375 8/20 0.64
PDE4A P27815 4/20 0.57
PDE4B Q07343 4/20 0.57
PDE4C Q08493 4/20 0.57
PDE4D Q08499 4/20 0.57
KDM4E B2RXH2 1/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
HPGD P15428 1/20 0.51
ALOX12 P18054 1/20 0.51
NFKB1 P19838 1/20 0.51
APEX1 P27695 1/20 0.51
MAPK1 P28482 1/20 0.51
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15664377 0.89 TNF (0.61) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL3338144 0.89 TNF (0.61) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL23112417 0.89 TNF (0.61) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL29441529 0.87 TNF (0.72) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL6694358 0.87 TNF (0.72) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL6692799 0.85 TNF (0.59) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL6693845 0.85 TNF (0.79) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL6691510 0.85 TNF (0.57) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL9254916 0.84 ALDH1A1 (0.59) ALDH1A1HSD17B10L3MBTL1TNFPDE4A
SCHEMBL6690018 0.84 TNF (0.78) ALDH1A1HSD17B10L3MBTL1TNFPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477486-A2 Imides as inhibitors of TNF alpha CELGENE CORPORATION (US) 2004-11-17 EP claimed
EP-1477486-A2 Imides as inhibitors of TNF alpha CELGENE CORPORATION (US) 2004-11-17 EP disclosed
EP-0706521-B1 IMIDES AS TNF ALPHA INHIBITORS CELGENE CORP (US) 2002-10-02 EP disclosed
US-6200987-B1 ADMINISTERING AS TUMOR NECROSIS FACTOR INHIBITORS; CACHEXIA, ENDOTOXIN SHOCK; RETROVIRUS VIRICIDES CELGENE CORPORATION 2001-03-13 US disclosed
US-6075041-A TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 2000-06-13 US disclosed
EP-1004581-A2 Process for the preparation of thalidomide CELGENE CORPORATION (US) 2000-05-31 EP disclosed
EP-1004572-A2 Amines as inhibitors of TNF alpha CELGENE CORPORATION (US) 2000-05-31 EP disclosed
EP-1004580-A2 Imides as inhibitors of TNF alpha CELGENE CORPORATION (US) 2000-05-31 EP disclosed
US-5877200-A Cyclic amides CELGENE CORPORATION (US) 1999-03-02 US disclosed
US-5698579-A INHIBITOR OF TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 1997-12-16 US disclosed
US-5605914-A INHIBITORS OF TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 1997-02-25 US disclosed
EP-0706521-A1 NOVEL IMIDES CELGENE CORPORATION (US) 1996-04-17 EP disclosed
US-5466825-A Bleaches SOLVAY INTEROX LIMITED (GB) 1995-11-14 US disclosed
US-5463063-A Preparation of thalidomide; inhibitor of tumor necrosis factor CELGENE CORPORATION (US) 1995-10-31 US disclosed
WO-1995001348-A2 IMIDES AS INHIBITORS OF TNP ALPHA CELGENE CORPORATION (US) 1995-01-12 WO disclosed